These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9843755)

  • 21. Recurrence of hepatitis C virus infection after orthotopic liver transplantation.
    Martin P; Muñoz SJ; Di Bisceglie AM; Rubin R; Waggoner JG; Armenti VT; Moritz MJ; Jarrell BE; Maddrey WC
    Hepatology; 1991 Apr; 13(4):719-21. PubMed ID: 1901291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcome of hepatitis C virus infection after liver transplantation.
    Böker KH; Dalley G; Bahr MJ; Maschek H; Tillmann HL; Trautwein C; Oldhaver K; Bode U; Pichlmayr R; Manns MP
    Hepatology; 1997 Jan; 25(1):203-10. PubMed ID: 8985291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].
    Lucena JF; Herrero JI
    An Sist Sanit Navar; 2004; 27 Suppl 2():91-101. PubMed ID: 15381947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection.
    Gonzalez-Peralta RP; Davis GL; Lau JY
    J Hepatol; 1994 Aug; 21(2):255-9. PubMed ID: 7989719
    [No Abstract]   [Full Text] [Related]  

  • 25. The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease.
    Alberti A; Pontisso P; Chemello L; Fattovich G; Benvegnù L; Belussi F; De Mitri MS
    J Hepatol; 1995; 22(1 Suppl):38-41. PubMed ID: 7602074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C recurrence after liver transplantation.
    Bhat I; Mukherjee S
    Panminerva Med; 2009 Dec; 51(4):235-47. PubMed ID: 20195234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytokine mediators in acute inflammation and chronic course of viral hepatitis].
    Missale G; Ferrari C; Fiaccadori F
    Ann Ital Med Int; 1995; 10(1):14-8. PubMed ID: 7727201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future of liver transplantation for viral hepatitis.
    Durand F; Francoz C
    Liver Int; 2017 Jan; 37 Suppl 1():130-135. PubMed ID: 28052618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Course of the recurrence of hepatitis C virus infection after liver transplantation].
    Gugenheim J; Baldini E; Ouzan D; Mazza D; Saint-Paul MC; Goubaux B; Mouiel J
    Gastroenterol Clin Biol; 1996; 20(10):730-5. PubMed ID: 8991141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of hepatitis C virus in the transplant patient.
    Berenguer M
    Clin Liver Dis; 2007 May; 11(2):355-76. PubMed ID: 17606212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical picture and evolution of hepatitis C].
    Marcellin P; Erlinger S
    Bull Acad Natl Med; 1996; 180(6):1267-76; discussion 1276-8. PubMed ID: 8991608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients.
    Testa G; Crippin JS; Netto GJ; Goldstein RM; Jennings LW; Brkic BS; Brooks BK; Levy MF; Gonwa TA; Klintmalm GB
    Liver Transpl; 2000 Sep; 6(5):553-61. PubMed ID: 10980053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Orthotopic liver transplantation in hepatic cirrhosis: on the problem of infection of the transplant with persistent hepatitis viruses].
    Hopf U; Neuhaus P; König V; Bauditz J; Küther S; Schmidt CA; Steffen R; Blumhardt G; Bechstein WO; Neuhaus R
    Z Gastroenterol; 1992 Sep; 30(9):576-82. PubMed ID: 1449005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of hepatitis C virus infection recurrence after liver transplantation: an overview.
    Ponziani FR; Gasbarrini A; Pompili M; Burra P; Fagiuoli S
    Transplant Proc; 2011; 43(1):291-5. PubMed ID: 21335208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation.
    Negro F; Giostra E; Rubbia-Brandt L; Mentha G; Colucci G; Morel P; Quadri R; Perrin L; Hadengue A
    J Med Virol; 1998 Nov; 56(3):224-9. PubMed ID: 9783689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients.
    Gane E
    Liver Transpl; 2003 Nov; 9(11):S28-34. PubMed ID: 14586892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are posttransplantation protocol liver biopsies useful in the long term?
    Berenguer M; Rayón JM; Prieto M; Aguilera V; Nicolás D; Ortiz V; Carrasco D; López-Andujar R; Mir J; Berenguer J
    Liver Transpl; 2001 Sep; 7(9):790-6. PubMed ID: 11552213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell response in hepatitis C virus infection.
    Neumann-Haefelin C; Blum HE; Chisari FV; Thimme R
    J Clin Virol; 2005 Feb; 32(2):75-85. PubMed ID: 15653409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.